Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2398.2000 -8.10 (-0.34%)
NSE Oct 01, 2025 15:31 PM
Volume: 59,633
 

logo
Ajanta Pharma Ltd.
30 Jan 2018
2398.20
-0.34%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 10% YoY to | 587 crore (I-direct estimate: | 553 crore) mainly due to 15% growth in export formulations, led by 79% growth in the Asia business to | 161 crore and ~20% growth in the US to | 71 crore. Domestic sales grew 4% YoY to | 155 crore EBITDA margins improved 36 bps YoY to 33.6% (I-direct estimate: 33.5%) mainly due to an improvement in gross margins by 123 bps YoY to 81.3%. EBITDA increased 11% YoY to | 198 crore...
Prabhudas Lilladhar released a Buy report for Ajanta Pharma Ltd. with a price target of 3200.0 on 19 Sep, 2025.
More from Ajanta Pharma Ltd.
Recommended